Sunshine Biopharma (SBFM) Notes Payables (2012 - 2021)
Sunshine Biopharma (SBFM) posted Notes Payables of $330000.0 for Q3 2021, little changed on a QoQ basis from $330000.0 in Q2 2021, and down 37.76% year-over-year from $530209.0 in Q3 2020.
Sunshine Biopharma (SBFM) Notes Payables (2012 - 2021) Analysis & Trends
Sunshine Biopharma's Notes Payables history runs 9 years deep, the most recent figure standing at $330000.0 for Q3 2021.
- Quarterly Notes Payables fell 37.76% year-over-year to $330000.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $330000.0 (down 37.76% YoY) and the FY2020 annual result came in at $143661.0, up 11.14% from the prior year.
- Notes Payables was $330000.0 for Q3 2021 at Sunshine Biopharma, roughly flat from $330000.0 in the prior quarter.
- Across five years, Notes Payables topped out at $745397.0 in Q1 2019 and bottomed at $3915.0 in Q1 2018.
- A 5-year average of $271364.8 and a median of $200177.0 in 2017 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2018 — Notes Payables tumbled 97.87% — and 2019, when it jumped 18939.51%.
- Sunshine Biopharma's Notes Payables stood at $516867.0 in 2017, then retreated by 18.81% to $419663.0 in 2018, then sank by 69.2% to $129261.0 in 2019, then advanced by 11.14% to $143661.0 in 2020, then surged by 129.71% to $330000.0 in 2021.
- Business Quant data shows SBFM's Notes Payables at $330000.0 in Q3 2021, $330000.0 in Q2 2021, and $143661.0 in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 330,000.00 |
| Jun 30, 2021 | 330,000.00 |
| Mar 31, 2021 | 143,661.00 |
| Dec 31, 2020 | 143,661.00 |
| Sep 30, 2020 | 530,209.00 |
| Jun 30, 2020 | 128,269.00 |
| Mar 31, 2020 | 513,407.00 |
| Dec 31, 2019 | 129,261.00 |
| Sep 30, 2019 | 88,751.00 |
| Jun 30, 2019 | 89,808.00 |
| Mar 31, 2019 | 745,397.00 |
| Dec 31, 2018 | 419,663.00 |
| Sep 30, 2018 | 225,195.00 |
| Jun 30, 2018 | 242,672.00 |
| Mar 31, 2018 | 3,915.00 |
| Dec 31, 2017 | 516,867.00 |
| Sep 30, 2017 | 200,177.00 |
| Jun 30, 2017 | 191,129.00 |
| Mar 31, 2017 | 183,889.00 |
| Dec 31, 2016 | 69,939.00 |